---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-011732"
form_type: "8-K"
ticker: "SYRA"
cik: "0001922335"
company_name: "Syra Health Corp"
filed_at: "2025-05-20T23:59:59+00:00"
generated_at: "2026-05-21T00:33:06.025705+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Syra Health board launches national CEO search; Vuppalanchi interim

## Summary
- Board initiates a national search for a new CEO to succeed current CEO Dr. Deepika Vuppalanchi.
- Dr. Vuppalanchi will serve as interim CEO until a successor is appointed.
- Co-founder Vuppalanchi is expected to remain on the leadership team post-transition.
- Transition is described as a strategic succession plan for next growth phase.

## SEC filing metadata
- accession: 0001641172-25-011732
- form_type: 8-K
- ticker: SYRA
- cik: 0001922335
- company_name: Syra Health Corp
- filed_at: 2025-05-20T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1922335/000164117225011732/0001641172-25-011732-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1922335/000164117225011732/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-011732
- JSON: https://secwatch.observer/filing/0001641172-25-011732.json
- Plain text: https://secwatch.observer/filing/0001641172-25-011732.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.